CryoValve® SG Aortic Human Heart Valve Combination Study

NCT01236469 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2015-08-19

No results posted yet for this study

Summary

The purpose of this study is to assess the probable benefit of CryoValve SG Aortic Human Heart Valve used in pediatric patients as an aortic valve replacement.

Conditions

  • Aortic Valve Stenosis
  • Aortic Valve Insufficiency

Interventions

PROCEDURE

Echocardiogram

A prospective follow-up Study Echocardiogram will be performed, as applicable, for those subjects who do not have echo data as of January 1, 2009.

Sponsors & Collaborators

  • CryoLife, Inc.

    lead INDUSTRY

Principal Investigators

  • Scott B Capps, MS · CryoLife, Inc.

Eligibility

Min Age
6 Years
Max Age
27 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-06-30
Primary Completion
2011-05-31
Completion
2012-02-29

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01236469 on ClinicalTrials.gov